Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
A collaborative of Dartmouth’s Geisel School of Medicine, Muhimbili University of Health and Allied Sciences in Tanzania, and Tokyo Medical and Dental University received $1.4 million from Japan’s Global Health Innovative Technology Fund to conduct a joint randomized clinical trial in Tanzania aimed at reducing the transmission of tuberculosis.
Geisel medical student Tara Kedia checks in from Haiti, where this summer she is working on two projects related to the detection and diagnosis of tuberculosis.
Despite political tensions between Iran and the U.S., Nicholas Hill, a 1973 graduate of Dartmouth’s medical school, has worked with Iranian pulmonologists to improve the treatment of tuberculosis.
A recent grant will bolster a longstanding partnership between Geisel and Muhimbili University of Health and Allied Sciences in Tanzania.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.